Moreover, an ARID1A‐deficient ovarian cancer mice model displayed an increased mutation load, elevated numbers of tumor‐infiltrating lymphocytes, and higher PD‐L1 expression levels.29 This evidence concerns the gene ARID1A and ovarian cancer.